BIO-key resumes Nasdaq trading after regaining compliance.
BIO-key International announced its shares will resume trading on Nasdaq starting July 8, following a panel's decision that the company has regained compliance with listing require…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
BIO-key International announced its shares will resume trading on Nasdaq starting July 8, following a panel's decision that the company has regained compliance with listing require…
Theriva Biologics obtained regulatory authorization from the Spanish Agency for the VIRAGE2 clinical trial testing increased VCN-01 dosing in metastatic pancreatic cancer. This stu…
Aptera Motors received an EPA Certificate of Conformity for its 2026 Launch Edition, confirming emissions compliance for U.S. sale. This regulatory milestone brings the company clo…
Tvardi announced positive Phase 1 results for its STAT3 prodrug TTI-109, demonstrating target engagement and significantly improved tolerability compared to the parent compound. Th…
Polomar Health Services filed updated amended and restated bylaws to define shareholder meetings and board authority. This document update is a routine governance measure with no i…
Dell Technologies Inc. filed amended and restated bylaws effective July 1, 2026. This regulatory filing updates the company's internal governance procedures and voting rules.
The company filed an amendment to its Articles of Incorporation as Exhibit 3.1. This regulatory action typically signifies a change in corporate governance or authorized capital st…
Invivyd confirmed the FDA will terminate the Emergency Use Authorization for PEMGARDA on June 29, 2027. Although the company intends to pursue permanent approval, the eventual loss…
W. P. Carey Inc. entered into a supplemental indenture dated July 2, 2026 to amend its 2014 debt indenture. This legal document updates the terms regarding the issuance of unsecure…
ABVC Biopharma addressed the SEC to validate the auditor change disclosed in its July 1, 2026 8-K. This documentation signifies compliance with procedural requirements for accounti…
PIMCO Asset-Based Lending reports a net asset value of $10.31 per share as of May 31, 2026. Total equity reached $523.97 million across all outstanding share classes.
The Federal Reserve issued an enforcement action against Small Business Bank. The Board also terminated enforcement actions against BNP Paribas entities and Community Bankshares, I…
The trust filed a standard SEC current report on July 2, 2026. The provided excerpt contains only header information and no specific operational or financial updates.
BBCMS Mortgage Trust 2024-5C27 filed a Current Report on Form 8-K dated July 2, 2026. The document provided only covers the cover page and registrant details, omitting the explanat…
Tenax confirmed it will present its Phase 3 LEVEL trial results at the ESC Congress 2026. This presentation reviews levosimendan's potential to treat PH-HFpEF.
The FDA approved Casgevy for patients aged two and older with either sickle cell disease or transfusion-dependent beta thalassemia. This supplement allows treatment for children ex…
The Federal Reserve published preliminary findings from the 2025 triennial study on U.S. payments. The analysis details the status of payments infrastructure and transaction flows …
Missouri American Water filed a request with the Missouri Public Service Commission to support $1.6 billion in water system upgrades over the next three years. The filing proposes …
The company will release close look at Phase 1/2a data for its 212Pb-based candidates targeting NETs and melanoma. These data, detailing efficacy and safety, could draw investor at…
Ernst & Young LLP signed off on the content of the company's July 1, 2026 8-K filing. The filing ensures regulatory compliance and third-party sign-off on financial disclosures.